Lancashire and South Cumbria Formulary Home Admin netFormulary Chapters Medicines A-Z News Mobile Reports Feedback  Search  Document Library All Pathways and Guidance | Change log | High Cost Drugs | LSC Critical Care Medicines Information | LSC ICS proxy ordering of medications in care homes | LSC Respiratory Resources | LSCMMG Consultations | LSCMMG Endorsed Secondary Care Guidelines | LSCMMG Minutes | LSCMMG Workplans | LSCMMG: About | New Medicine Reviews | PGDs | Place documents | Shared Care Guidelines | All Pathways and Guidance   Antihistamine: Position Statement  Antipsychotics: second generation long-acting injection (LAI) antipsychotics  Asthma Treatment Guideline for Children aged (11 and under)  Asthma Treatment Guidelines for Adults (Aged 12 and over)  Atrial Fibrillation: Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease  Axial Spondyloarthritis: High Cost Drugs Commissioning Pathway  Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement  Biosimilars policy statement  Branded Generics: Position Statement  Camouflaging Products: Position Statement  Colistimethate for nebulisation: Prescribing Information Sheet  Constipation: Primary Care Pathways  COPD Desktop Guideline  Degarelix: Prescribing Information Sheet  Dementia: Management of Behavioural and Psychological Symptoms of Dementia - Primary Care Summary Document  Dementia: Management of Behavioural and Psychological Symptoms of Dementia in Primary and Secondary Care  Dementia: Prescribing Information Sheet  Denosumab: Position Statement  Diabetes - Choice of Safety Pen Needles and Lancets  Diabetes - Pen Needles/Lancets  Diabetes - Position Statement Safety Needles and Safety Lancets  Diabetes -GLP-1 Agreement form (updated Jan 26)  Diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes  Diabetes: Recommended meters, strips and devices  Diabetes: Type 2 diabetes self management plan  Dosulepin: Guidelines for Primary Care  DXA scan prescribing information sheet  E-Cigarettes: Position Statement  Erectile Dysfunction Guideline  Eye: LSC Community Urgent Eye Service (CUES)  Fentanyl patch application guidance for patients - adults only  Fluoride High Strength Toothpastes: Position Statement  Gabapentinoid (pregabalin and gabapentin):De-prescribing guidance for non-cancer pain in adults in primary care  Gender incongruence: NHSE guidance to primary care about unregulated providers who supply hormone medications to children and young people for gender incongruence  Gluten-Free food products: Position Statement  Good prescribing in primary care guidance document July 2025 (Updated December 2025)  Gout Prescribing Guidance  Guidelines for the prescribing of Agomelatine  Headache Management Guideline For Adults  HidraWear: Position Statement  Hydroxychloroquine: Prescribing Information Sheet  Hypertension in Adults: Diagnosis and Management  Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement  Inflammatory Bowel Disease​: High Cost Drugs Commissioning Pathway  Insomnia in Adults  Insulin Safety (Six Steps) – for Community Settings  Insulin Toujeo: Information Sheet and Good Practice Guide  Items which should not routinely be prescribed in primary care: policy guidance  Ivabradine: Prescribing Information Sheet  Juvenile Idiopathic Arthritis in adult patients: Position statement for biological agents  Lancashire and South Cumbria Infant Feeding Network - Diagnosis and Management of Milk Allergy and Intolerance Guideline  Levetiracetam (Keppra®) prescribing: bioequivalence and antiepileptic drugs: Position Statement  Linezolid: Prescribing Information Sheet  Lipid Management Pathway for Primary Prevention of Cardiovascular Disease (CVD)  Lipid Management: Pathway for Secondary Prevention of Cardiovascular Disease (CVD)  Lithium Side Effects Rating Scale (LiSERS)  LSC Statin Intolerance Pathway  LSCMMG: Melatonin Pathway (Children)  Mesalazine: Prescribing Information Sheet  Morphine (High dose) prescribing for chronic non-cancer pain: Position Statement  Neuropathic Pain: Primary Care Management  Opioid reduction: best interests opioid reduction position statement  OpioId treatment: patient-prescriber opioid treatment agreement  Opthalmology Macular Pathways  Oral Nutritional Supplements in Primary Care  Osteoporosis: Secondary fracture prevention patient treatment pathway  Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy  Overactive bladder in female adults  Palliative Care Clinical Practice Summary See more information under chapter 21 'Palliative Care Formulary'.  Paracetamol – prescribing weight-adjusted paracetamol in adults in the community  PKU (Phlexy-Vit) Prescribing of multivitamins and phenylalanine-free amino acid substitutes for adults and children  Position Statement on Prescribing Shower Protection Pouches  POSITION STATEMENT: Monitored dosage systems (MDS) and seven-day prescriptions  Prescribing: requests from out of area  Private prescribing: patients presenting at an NHS GP practice following a private episode of care  Proton pump inhibitor (PPI): Primary Care Review Pathway  Psoriasis in adults: LSCMMG Biologic and High Cost Drug Commissioning Pathway  Psoriasis: primary care guidance document  Psoriatic Arthritis: High Cost Drugs Commissioning Pathway  Recurrent Urinary Tract Infection: LSCMMG Treatment Pathway (Adults)  Renal: Enhanced Supportive Kidney Care Guideline  Restless Legs Syndrome in Adults in Primary Care  Rheumatoid Arthritis: High Cost Drugs Commissioning Pathway  Riluzole: Patient Information  Scabies operational clinical pathway  Somatropin: Prescribing Information Leaflet  Stoma and continence Products Prescription Management guide  Tapentadol MR position statement  Tirzepatide for Type 2 Diabetes position statement  Tirzepatide: LSC ICB specialist weight management support in Lancashire and South Cumbria (June 2025)  Topiramate (Topamax) - Update for Primary Care: New Pregnancy Prevention Programme  Trans female gender dysphoria: Prescribing information sheet  Trans male gender dysphoria: Prescribing information sheet  UNDER REVIEW Pain: Assessing suitability for strong opioid use  Vaginal devices for female urinary stress incontinence